跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REVOLADE eltrombopag 75mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
REVOLADE eltrombopag 75mg film-coated tablet blister pack
Approved
STANDARD
REVOLADE eltrombopag 75mg film-coated tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5275ae709f8af2a6
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
5275ae709f8af2a6
Product Name
REVOLADE eltrombopag 75mg film-coated tablet blister pack
Artg Id
200121
Artg Name
REVOLADE eltrombopag 75mg film-coated tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2013-09-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/f51291b870ac09c1fb957f1b7f471d63.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5275ae709f8af2a6
Type
Standard
Back to TGA Approvals